No. | Publication Date | Citing Article |
---|---|---|
1 | 2022 | Yan-Ni Wang, Hong-Jiao Liu, Li-Li Ren, Ping Suo, Liang Zou, Ya-Mei Zhang, Xiao-Yong Yu, Ying-Yong Zhao. Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway, Frontiers in Pharmacology. 2022; 13: 964370. https://doi.org/10.3389/fphar.2022.964370 |
2 | 2024 | Diana V. Ávila-Martínez, Wendy K. Mixtega-Ruiz, José M. Hurtado-Capetillo, Oscar Lopez-Franco, Mónica Flores-Muñoz. Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?, Frontiers in Pharmacology. 2024; 15: 1377113. https://doi.org/10.3389/fphar.2024.1377113 |